Related Experiment Video
Updated: Jun 28, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Infant botulism: two recent cases and literature review
Rose M Domingo1, Jerome S Haller, Michael Gruenthal
1Department of Neurology, Albany Medical Center Hospital, Albany, New York 12208, USA. DomingR@mail.amc.edu
Journal of Child Neurology
|November 6, 2008
Summary
Infant botulism, a serious infant illness, requires prompt diagnosis and treatment. Early recognition and supportive care, including human botulism immune globulin, improve outcomes for affected infants.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Toxicology
Background:
- Infant botulism poses a significant health risk in the United States.
- Early recognition and supportive care are crucial for improving clinical outcomes.
- Human botulism immune globulin (BIG-IV) was approved by the FDA in 2003 for infant botulism treatment.
Observation:
- Two cases of infant botulism occurred in Upstate New York during spring/summer 2007.
- Both cases were suspected to be linked to environmental dust and Clostridium botulinum spores in soil.
- Clinical suspicion remains the primary method for diagnosing infant botulism.
Findings:
- The report details two pediatric cases of infant botulism.
- A literature review covers infant botulism's pathophysiology, clinical features, epidemiology, and treatment.
- Prompt initiation of therapy is emphasized for better patient outcomes.
Implications:
- This case series highlights the importance of environmental factors in infant botulism.
- Understanding epidemiology and clinical features aids in early diagnosis and management.
- Timely administration of human botulism immune globulin is critical for infant recovery.
Related Concept Videos
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...